Skip to content
AI Trainer Jobs
Companies

Biotech Investment Analyst — Drug Asset & Company Assessment

Mercor · 100% remote · Contract · Posted

Pay
$120–200/hr
Location
United States
Languages
English
Hours
10-20 hours over 1-2 week pilot
Openings
Not listed
Level
Experienced
Apply for this position

Summary

Assess biotech drug assets and companies, create and critique evaluation rubrics, and judge investment theses for a pilot set of 5-10 companies.

What you'll do

  • Create and critique rubrics that analyze commercial drugs and drug-development programs
  • Provide overall company and asset assessment covering mechanism, clinical data, competitive position, and value drivers
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
  • Apply the assessment across the pilot's set of companies, roughly 5-10

Requirements

  • Be a US-based biotech or healthcare investment analyst with a specialist-fund background
  • Be familiar with biotech and pharma development programs
  • Assess a drug asset and the company behind it end-to-end
  • Have 5+ years evaluating biotech or pharma companies or assets

Skills

  • Biotech Investment Analysis
  • Pharmaceutical Development
  • Clinical Data Evaluation
  • Competitive Positioning
  • Investment Thesis Writing

Full description

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs

  • Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers

  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions

  • Apply your assessment across the pilot's set of companies (~5–10)

Requirements

  • US-based biotech / healthcare investment analyst with a specialist-fund background

  • Familiarity with biotech/pharma development programs

  • Able to assess a drug asset and the company behind it end-to-end

  • 5+ years evaluating biotech/pharma companies or assets

Engagement Details

  • Duration: Approximately 10–20 hours over a 1–2 week pilot

  • Remote — US-based

Why Participate

  • Help improve expert AI evaluation of drugs and drug-development programs

  • Recurring engagement for strong contributors

Similar jobs

View all jobs